A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation-Reference-Cited by-同舟云学术

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation

Published:2021-10-18 Issue:1 Volume:22 Page:222-229
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American J Transplantation

Author:

Neurohr Claus¹²,Kneidinger Nikolaus¹^ORCID,Ghiani Alessandro²,Monforte Víctor³^ORCID,Knoop Christiane⁴,Jaksch Peter⁵,Parmar Jasvir⁶,Ussetti Piedad⁷,Sole Amparo⁸,Müller‐Quernheim Joachim⁹,Kessler Romain¹⁰,Wirtz Hubert¹¹,Boerner Gerhard¹²,Denk Oliver¹²,Prante Fernandes Stefanie¹²,Behr Juergen¹

Affiliation:

1. Department of Medicine V University Hospital LMU Munich German Center for Lung Research (DZL) Munich Germany

2. Department of Pulmonology and Respiratory Medicine Robert‐Bosch‐Krankenhaus Stuttgart Stuttgart Germany

3. Hospital Universitari Vall d’Hebron Barcelona Spain

4. CHU Erasme Université Libre de Bruxelles Brussel Belgium

5. Department of Thoracic Surgery Medical University of Vienna Vienna Austria

6. Royal Papworth Hospital Cambridge United Kingdom

7. Hospital Universitario Puerta de Hierro Madrid Spain

8. Hospital Universitario La Fe Valencia Spain

9. Department of Pneumology Medical Center – University of Freiburg Faculty of Medicine University of Freiburg Freiburg Germany

10. Hopitaux Universitaires de Strasbourg Strasbourg France

11. Department of Respiratory Medicine University Hospital Leipzig Leipzig Germany

12. BREATH Therapeutics – a Zambon Group Company Munich Germany

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16858

Reference18 articles.

1. Bronchiolitis obliterans syndrome–free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis

2. Lung volumes predict survival in patients with chronic lung allograft dysfunction

3. BOS Is Associated With Increased Cytotoxic Proinflammatory CD8 T, NKT-Like, and NK Cells in the Small Airways

4. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients;Penninga L;Cochrane Database Syst Rev,2013

5. Future direction of immunosuppression in lung transplantation

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives;Pharmaceutics;2024-01-24

2. Inhalation Lenalidomide-Loaded Liposome for Bleomycin-Induced Pulmonary Fibrosis Improvement;AAPS PharmSciTech;2023-11-16

3. Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction;Pharmacological Reviews;2023-06-09

4. La dysfonction chronique du greffon pulmonaire en 2022 : une entité mieux comprise et un défi thérapeutique;Revue des Maladies Respiratoires;2023-04

5. Immunosuppression in lung transplantation: a narrative review;Current Challenges in Thoracic Surgery;2023-04